Selective down-regulation of D1 dopamine mediated rotational behavior in supersensitive mice. 1988

J D Winkler, and K Callison, and S A Cass, and B Weiss
Division of Neuropsychopharmacology, Medical College of Pennsylvania, Eastern Pennsylvania Psychiatric Institute, Philadelphia 19129.

The effects of continuous exposure to selective D1 and D2 agonists on rotational behavior were examined in mice with unilateral 6-hydroxydopamine-induced lesions of the corpus striatum. Continuously exposing mice to the D1 agonist SKF 38393 produced an initial rotational behavioral response which decreased dramatically within 4 hours. At the time these rotations ceased, the mice were totally unresponsive to an acute challenge injection of SKF 38393 but responded normally to an acute injection of the D2 agonist quinpirole. Mice chronically implanted with quinpirole also showed marked rotational behavior, but in contrast to the results with SKF 38393, essentially no diminution of these rotations was seen during a one week period of exposure. The results suggest that there are different mechanisms involved in the long term regulation of D1 and D2 dopamine systems in supersensitive animals.

UI MeSH Term Description Entries
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001067 Appetite Depressants Agents that are used to suppress appetite. Anorectic,Anorectic Agent,Anorectics,Anorexic Drug,Anorexigenic Drug,Appetite Depressant,Appetite Suppressant,Appetite Suppressants,Appetite-Depressing Drug,Appetite-Suppressant Drug,Anorectic Agents,Anorexic Drugs,Anorexigenic Drugs,Appetite-Depressing Drugs,Appetite-Suppressant Drugs,Agent, Anorectic,Agents, Anorectic,Appetite Depressing Drug,Appetite Depressing Drugs,Appetite Suppressant Drug,Appetite Suppressant Drugs,Depressant, Appetite,Depressants, Appetite,Drug, Anorexic,Drug, Anorexigenic,Drug, Appetite-Depressing,Drug, Appetite-Suppressant,Drugs, Anorexic,Drugs, Anorexigenic,Drugs, Appetite-Depressing,Drugs, Appetite-Suppressant,Suppressant, Appetite,Suppressants, Appetite
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

J D Winkler, and K Callison, and S A Cass, and B Weiss
May 1989, The Journal of pharmacology and experimental therapeutics,
J D Winkler, and K Callison, and S A Cass, and B Weiss
June 1988, Pharmacology, biochemistry, and behavior,
J D Winkler, and K Callison, and S A Cass, and B Weiss
July 1986, The Journal of pharmacology and experimental therapeutics,
J D Winkler, and K Callison, and S A Cass, and B Weiss
May 2005, International journal of molecular medicine,
J D Winkler, and K Callison, and S A Cass, and B Weiss
October 2008, Neuroreport,
J D Winkler, and K Callison, and S A Cass, and B Weiss
May 1999, Experimental neurology,
J D Winkler, and K Callison, and S A Cass, and B Weiss
June 1999, Pharmacology, biochemistry, and behavior,
J D Winkler, and K Callison, and S A Cass, and B Weiss
June 1993, European journal of pharmacology,
Copied contents to your clipboard!